Table 1 Baseline and clinical characteristics of the patients (n = 20)
Age (years) | 58.4 ± 7.8 |
Karnofsky Index | |
80% | 5 (25%) |
90% | 14 (70%) |
100% | 1 (5%) |
Size (cm) | 163.6 ± 3.8 |
Weight (kg) | 66.7 ± 11.7 |
Primary tumor localisation | |
Ovary | 16 (80%) |
Fallopian tube | 3 (15%) |
Peritoneal | 1 (5%) |
Histology | |
Serous | 13 (65%) |
Endometrial | 4 (20%) |
Others | 3 (15%) |
Tumor grade | |
G2 | 3 (15.8%) |
G3 | 16 (84.2%) |
missing | 1 |
Resection status | |
R0 | 17 (85%) |
R1 | 2 (10%) |
R2 (< 1 cm) | 1 (5%) |
Excised lymph nodes | 48.8 ± 25.2 |
Affected lymph nodes | 3.4 ± 5.7 |
pN | |
pN0 | 7 (35%) |
pN1 | 12 (60%) |
pN2 | 1 (5%) |
Staging | |
Ascites preoperatively | 14 (70%) |
Ascites postoperatively | 3 (15.8%) |
Affection of liver surface | 2 (10%) |
Peritoneal carcinosis | 17 (85%) |
bowel resection | 4 (20%) |
Tumor marker CA-125a | |
Preoperatively | 1625.7 ± 3567.0 |
317.0 (89.0, 1369.7) | |
Postoperatively | 160.7 ± 257.9 |
61.9 (21.8, 187.8) | |
After chemotherapy | 13.3 ± 7.4 |
13.4 (7.0, 18.6) | |
Before start of radiation | 14.5 ± 9.9 |
13.4 (6.8, 20.1) | |
6 weeks after radiation | 18.2 ± 17.5 |
9.5 (5.8, 29.1) | |